1 / 1

Promising Results in Reducing Risk of CDMS - Clinical Trial Findings

The study shows a significant 45% risk reduction to CDMS with a hazard ratio of 0.55 (95% CI 0.40-0.77, p=0.0005). Patients in the study group gained on average 386 days, an increase of 115% from day 336 to day 722. Based on Comi G.'s work presented at AAN 2008 (LBS.003).

gizela
Download Presentation

Promising Results in Reducing Risk of CDMS - Clinical Trial Findings

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. PreCISe Primary End Point: Risk Reduction to CDMS Placebo Risk Reduction of 45% Hazard Ratio= 0.55 [95% CI] 0.40-0.77 P=0.0005 GA + 386 days: + 115% Day 336 Day 722 Adapted from Comi G. AAN 2008, LBS.003.

More Related